Navigation Links
Monsanto Board Approves 10 Percent Dividend Increase
Date:1/14/2009

ST. LOUIS, Jan. 14 /PRNewswire-FirstCall/ -- As the latest step in its ongoing commitment to return value to shareowners, Monsanto Company (NYSE: MON) today announced that its Board of Directors declared a 10 percent increase in the quarterly dividend on its common shares from 24 cents per share to 26.5 cents per share. The dividend is payable on April 24, 2009 to shareowners of record on April 3, 2009.

"As we have often said, when farmers succeed we succeed, and we are pleased to share our company's continued success with our shareowners through the increase of our quarterly dividend," said Terry Crews, Executive Vice President and Chief Financial Officer of Monsanto. "The combination of our company's performance, our financial discipline and the board's ongoing confidence in our business strategy makes this opportunity possible."

The dividend relates to the company's second quarter of its 2009 fiscal year. Since Monsanto was spun off as an independent company in August 2002, its Board of Directors has raised the dividend eight times for a total increase of more than 340 percent.

Crews noted that the dividend is one of the key elements of Monsanto's three-pronged approach to using its strong cash position to benefit shareowners. These include: investing in strategic acquisitions or collaborations, supporting business growth through capital spending, and bolstering direct return to shareowners through increased dividends and share repurchases.

About Monsanto Company

Monsanto Company is a leading global provider of technology-based solutions and agricultural products that improve farm productivity and food quality. Monsanto remains focused on enabling both small-holder and large-scale farmers to produce more from their land while conserving more of our world's natural resources such as water and energy. To learn more about our business and our commitments, please visit: http://www.monsanto.com.


'/>"/>
SOURCE Monsanto Company
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Monsanto Recognized as Top Biotechnology Employer by Science Magazine
2. Monsanto Sees Growing Opportunity for Biotech Traits Globally
3. New Insect Protection Technology From Monsanto Company Deregulated by USDA
4. Monsanto Announces Key Regulatory Approvals for Roundup Ready 2 Yield(TM) Soybeans; Product Remains on Track for 2009 Launch
5. Monsantos Industry-Leading Seed Position Creates Accelerated Biotech Trait Opportunity in Latin America
6. Monsanto Company and Mendel Biotechnology Announce Cellulosic Biofuels Collaboration
7. Monsanto Executives to Address Investor Conferences in February
8. National Academy of Sciences Recognizes Monsantos Chief Technology Officer for Development of Agricultural Biotechnology
9. Monsantos R&D Pipeline Set to Deliver Valuable Products to Farmers Well Into Next Decade
10. Monsanto and Devgen Describe New Approach to Insect-Protection
11. Monsanto Company Executives Adopt 10b5-1 Trading Plans
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/9/2016)... The research report by Transparency ... the  Global Label-Free Array Systems Market  accounted for a ... Players such as Biacore, Agilent Technologies, ForteBio, Molecular Devices ... global market due to their unmatched product portfolio and ... and timely product launches are expected to be the ...
(Date:12/9/2016)... India , December 9, 2016 According ... & Services (Primer, Probe, Custom, Predesigned, Reagent Equipment), Application (Research, PCR, ... Forecasts to 2021" published by MarketsandMarkets, the global market is expected ... in 2016, at a CAGR of 10.6% during the forecast period. ... ...
(Date:12/8/2016)... DIEGO, Dec. 8, 2016  OncoSec Medical Incorporated ... developing DNA-based intratumoral cancer immunotherapies, today announced financial ... "We are delivering on our commitment ... with ImmunoPulse® IL-12. We are pleased with the ... combination trial, and we are focused on advancing ...
(Date:12/8/2016)... 8, 2016  Renova™ Therapeutics, a biotechnology company ... and type 2 diabetes, announced that it has ... virus (AAV) vector developed in the laboratory of ... Stanford University. The company plans to use this ... product pipeline. "Early research has ...
Breaking Biology Technology:
(Date:11/29/2016)... Nov. 29, 2016 BioDirection, a privately held ... for the objective detection of concussion and other traumatic ... successfully completed a meeting with the U.S. Food and ... test Pre-Submission Package. During the meeting company representatives reviewed ... a precursor to commencement of a planned pilot trial. ...
(Date:11/28/2016)... 2016 "The biometric system ... The biometric system market is in the growth ... near future. The biometric system market is expected to ... a CAGR of 16.79% between 2016 and 2022. Government ... technology in smartphones, rising use of biometric technology in ...
(Date:11/22/2016)... --  MedNet Solutions , an innovative SaaS-based eClinical technology ... is pleased to announce that the company has been ... Awards as "Most Outstanding in eClinical Solutions" for ... recognition and growth for MedNet, which has effectively supported ... iMedNet ™ , MedNet,s flagship eClinical technology ...
Breaking Biology News(10 mins):